Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 1998

View Archived Issues

Company Profile: Oxford BioMedica

Treatment of acute coronary syndromes by thrombin inhibition

The association between neuropathy and microcirculation in diabetic foot ulcers

Genzyme Tissue Repair: Q4 and year-end highlights

NeXstar: Q4 and FY 1997 highlights

Genzyme Transgenics: Q4 and year-end 1997 highlights

Zn2+ points the way to potent and specific protease inhibitors

Genzyme General: Q4 1997 highlights

Gene therapies for obesity revealed by Merck & Co., Baylor College of Medicine

Celgene expands phase I trial of TNF-alpha inhibitor

Improved anticoagulants in development at Gyogyszerkutato Intezet

NaPro's paclitaxel approved in Singapore

New methylcarbapenems from Sankyo

Novel neuroprotective substance isolated by Kirin Brewery

New antibacterial agents from Ortho

New malaria vaccine described in patent literature

Cornerstone patent awarded to Hyal

Biovail subsidiary in-licenses novel antiinflammatory/analgesic from Chiesi

First market introduction for Allegra-D

Techniclone to begin TNT clinical trials using unique delivery system

Procter & Gamble reports novel NSAIDs with improved GI safety

Thymus-specific chemokine protein disclosed by HGS

More antiobesity proteins emerge from Lilly research

Glaxo Wellcome, Boehringer Ingelheim collaborate to bring telmisartan to market

FDA advisory committee reaches a stand-off on orlistat recommendation

Immunosuppressive analogues of a natural immunostimulant

Research to begin on new approach to antibiotic therapy

Favorable results obtained with Enbrel combination in RA

Centocor completes acquisition of reteplase

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...